期刊文献+

异位子宫内膜干细胞的检测及其标志物研究 被引量:3

The Study of Identification of Ectopic Endometrial Stem Cells and Its Markers in Mouse Model of Endometriosis
下载PDF
导出
摘要 目的了解异位子宫内膜干细胞在病灶中的数量、分布及定位情况,并筛选其可能的标志物表达。方法在子宫内膜异位症裸鼠模型建造前24h开始进行5-溴脱氧尿苷(BrdU)脉冲标记,共5d。在标记结束后4h、1周、3周、5周、6周、7周、8周及9周,通过免疫组化检测异位病灶中BrdU的表达情况,确定标记滞留细胞(The label-retaining cells,LRCs)。通过免疫组化双染检测LRCs表面CD34和CD146的表达情况。结果腺上皮和间质的BrdU初始最大标记率分别为(69.89±0.78)%和(73.27±1.06)%,于第6周和8周时分别有约(2.07±0.19)%和(4.63±0.72)%的腺上皮和间质细胞仍保留标记,即为上皮和间质标记滞留细胞,多位于异位内膜与所种植的裸鼠组织的交界处。LRCs并不表达CD34,少数间质LRCs表达CD146。结论异位子宫内膜中有上皮和间质两种干细胞,主要定位于异位内膜与所种植的组织的交界处,CD34不是异位内膜干细胞的标志物,CD146表达于异位内膜干细胞,但并非其特异性标志物。 Objective To identify and locate adult stem cells in ectopic endometrium and to find their markers in en- dometriosis. Methods The female nude mice were pulse labeled using 5-bromo-2-deoxyuridine (BrdU) for 5 consecutive days, 24 h prior to the endometriosis rat model was established. The label-retaining cells (LRCs) were identified by detecting BrdU labeling rate using immunohistochemistry on 4 h, 1-week, 3-week, 5-week, 6-week,7-week, 8-week and 9-week after injection. The expression levels of CD34 and CD146 on LRCs were detected by double staining of immunohistochemistry.Resuits The maximum BrdU labeling rates were (69.89±0.78)% and (73.27±1.06)% for epithelial and stromal cells respective- ly. After a 6-week and 8-week chase, (2.07±0.19)% epithelial cells and (4.63±0.72)% stromal cells retained BrdU labeling respectively, which were considered to be epithelial and stromal LRCs. Both the epithelial LRCs and the stromal LRCs were mainly located in the boundary of the lesions. LRCs did not co-express CD34. CD146 co-expressed on a few stromal LRCs. Conclusion Two kinds of stem cells were identified successfully in ectopic endometrium by label-retaining cell approach, which were epithelial and stromal LRCs, both located in the boundary of the lesions. It seems that CD34 is not the marker for ectopic endometrial stem cells. C D 146 maybe the candidate marker for ectopic endometrium but without specificity.
出处 《天津医药》 CAS 北大核心 2013年第5期482-485,I0005,共5页 Tianjin Medical Journal
基金 天津医科大学资助课题(项目编号:2010ky49)
关键词 子宫内膜异位症 干细胞 染色与标记 溴脱氧尿苷 免疫组织化学 抗原抗原 疾病模型 动物 endometriosis stem cells staining and labeling bromodeoxyuridine immunohistochemistry antigens, CD34 antigens, CD146 disease models, animal
  • 相关文献

参考文献15

  • 1Oliveira FR, Dela Cruz C, Del Puerto HL,et al. Stem cells: are they the answer to the puzzling etiology of endometriosis[J]? Histol His- topathl, 2012, 27(1):23-29.
  • 2Kao AP, Wang KH, Chang CC, et al.Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model[J].Fertil Steril, 2011,95(4):1308-1315.
  • 3Chan RW, Ng EH, Yeung WS. Identification of cells with co|o- ny-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis[J]. Am J Pathol, 2011,178(6):2832-2844.
  • 4Zhang J,Niu C,Ye L,et al.Identification of the haematopoietic stem cell niche and coritrol of the niche size[J].Nature, 2003, 425(6960): 836-841.
  • 5Taniguchi M, Yamamoto N, Nakagawa T, et al. Identification of tym- panic border cells as slow-cycling cells in the cochlea[J]. PLoS One, 2012,7(10):e48544.
  • 6Nordvig AS, Owens DM, Morris RJ. CD133 in the Selection of Epi- dermal Stem Cells in Mice: Steps in the Right Direetion[J]. J Invest Dermatol, 2012,132(11):2492-2494.
  • 7Szotek PP,Chang HL,Zhang LH,et al.Aduh mouse myometrial la- bel-retaining cells divide in response to gonadotropin stimulation[J]. Stem Cells, 2007,25(5): 1317-1325.
  • 8Chan RW, Gargett CE.Gargett.Identification of Label-Retaining Cells in Mouse Endometrium[J]. Stem Cells. 2006, 24(6):1529 1538.
  • 9Zhang HB, Ren CP, Yang XY, et at. Identification of label-retain- ing cells in nasopharyngeal epithelia and nasopharyngeal carcino- ma tissues[J]. Histochem Cell Biol, 2007, 127(3):347-354.
  • 10Laschke MW, Giebels C, Nickels RM, et al. Endothelial progenitor cells contribute to the vaseularization of endometriotic lesions[J]. Am J Pathol, 2011,178(1):442-450.

同被引文献31

  • 10’ Brien CA, Pollett A, Gallinger S, et al. A human colon cancercell capable of initiating tumour growth in immunodeficient mice[J]. Nature, 2007,445(7123):106-110.
  • 2Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification andexpansion of human coion-cancer-initiating cells [J]. Nature, 2007,445(7123):111-115.
  • 3Kharas MG, Lengner CJ, Al-Shahrour F, et al. Musashi-2 regulatesnormal hematopoiesis and promotes aggressive myeloid leukemia[J]. Nat Med, 2010, 16(8):903-908.
  • 4Eramo A,Lotti F, Sette G,et al. Identification and expansion ofthe tumorigenic lung cancer stem cell population[J].Cell Death Dif-fer, 2008,15 ⑶:504-514.
  • 5Saigusa S, Tanaka K, Toiyama Y, et al. Immunohistochemical fea-tures of CD133 expression: association with resistance to chemora-diotherapy in rectal cancer[J].Oncol Rep, 2010,24(2):345-350.
  • 6MacNicol MC, Cragle CE, MacNicol AM. Context-dependent regu-lation of Musashi—mediated mRNA translation and cell cycle regula-tion[J]. Cell Cycle,2011, 10(1):39-44.
  • 7de Andr6s-Aguayo L, Varas F, Graf T, et al. Musashi-2 in hemato-poiesis[J]. Curr Opini Hematol, 2012,19(4):268-272.
  • 8Sureban SM, May R, George RJ,et al. Knockdown of RNA bindingprotein musashi-1 leads to tumor regression in vivo[J]_ Gastroenter-ology, 2008,134(5): 1448-1458.
  • 9Lugli A’Lezzi G,Hostettler I, et al.Prognostic impact of the expres-sion of putative cancer stem cell markers CD133, CD166, CD44s,EpCAM, and ALDH1 in colorectal cancer[J]. Br J Cancer,2010,103(3):382-390.
  • 10Mia-Jan K,Jung SY’Kim IY’et al.CD133 expression is not an inde-pendent prognostic factor in stage II and III colorectal cancer butmay predict the better outcome in patients with adjuvant therapy [J].BMC Cancer, 2013,13:166.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部